Gerry lives with PBC in Ireland. He struggles to access newer therapies available in the U.S. Why would the U.S. model European health care delays and denials? #MFNHurtsPatients#ValueOurHealth
PIPC and @UnitedSpinal requested changes to the VA National Formulary Act to ensure changes to the formulary development process are centered on patients and people with disabilities. #ValueOurHealth
"By tying U.S. drug prices to those set by nations that rely on QALYs, the MFN model effectively outsources American health policy to systems that do not share our civil rights protections."
Thank you @senatorcollins for calling out the dangers of #QALYs and the implications for discrimination by importing their use to the United States by reference. https://t.co/FyXtRJQLZq
Check out the Engagement in Health Research Literature Explorer, a streamlined resource with more than 2,000 peer-reviewed citations on patient engagement in health research.
Learn more: https://t.co/CkEPW3eesd
In Australia, families are still fighting to get younger children with severe eczema access to medicines older patients already receive through the pbs. The U.S. should not import pricing systems that delay access and leave families paying thousands out of pocket.
In Australia, families are still fighting to get younger children with severe eczema access to medicines older patients already receive through the pbs. The U.S. should not import pricing systems that delay access & leave families paying thousands out of pocket. #MFNHurtsPatients
We sincerely thank Governor Spanberger for hearing and acting on the disability community’s concerns regarding this legislation. https://t.co/aMCWrnzCfs
No patient or person with a disability is average. We look forward to future policy debates focusing on affordable access to care for people with disabilities and patients in a manner that is aligned with federal law and regulations governing disability nondiscrimination.